In conclusion, PD-1 monoclonal antibodies in tumor-associated macrophages can inhibit the migration and angiogenesis of cervical cancer cells by affecting the PD-1/IRE1α/SHP2/HIF1α signaling pathway, thereby inhibiting the progression of cervical cancer. This evidence concerns the gene PDCD1 and neoplasm.